Functional antagonism of IL-1alpha induced gene expression profiles define the cAMP/PKA pathway as a unique regulator

David L Murray1, Eric N Johnson, Ping Wang

  • 1Discovery Research and Chemoinformatics, GlaxoSmithKline, Research Triangle Park, NC 27709, USA. david.murray@roche.com

Insights

Interleukin-1 (IL-1alpha) triggers inflammation and fibrosis via MAPK/NFkappaB pathways. G(s)-coupled receptor agonists uniquely modulate these IL-1alpha responses, highlighting cAMP/PKA as a key regulatory point.

Area of Science:

  • Cellular and Molecular Biology
  • Immunology
  • Pharmacology

Background:

  • Interleukin-1 alpha (IL-1alpha) is a key mediator of inflammatory and pro-fibrotic responses in human lung fibroblasts.
  • These responses are primarily regulated by the activation of mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NFkappaB) signaling pathways.

Purpose of the Study:

  • To investigate the impact of various compounds, particularly those targeting MAPK and NFkappaB pathways, on IL-1alpha-induced gene expression changes.
  • To identify novel signaling mechanisms that modulate IL-1alpha-mediated responses in lung fibroblasts.

Main Methods:

  • Microarray analysis was employed to establish a reference gene set reflecting IL-1alpha-stimulated cellular responses.
  • The activity of different compounds, including G(s)-coupled receptor agonists, direct pathway inhibitors (p38, JNK, MEK, IKK inhibitors), forskolin, and cAMP analogs, was profiled.
  • Gene expression changes in response to IL-1alpha and compound treatments were analyzed to understand pathway modulation.

Main Results:

  • G(s)-coupled receptor agonists demonstrated a distinct pattern of gene expression modulation in IL-1alpha-stimulated cells.
  • These unique effects were not replicated by direct inhibitors of p38, JNK, MEK, or IKK.
  • Forskolin and cAMP analogs mimicked the effects of G(s)-coupled receptor agonists, suggesting a role for cAMP/PKA signaling.

Conclusions:

  • Cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA) act as a convergence point for regulating IL-1alpha responses mediated by various G(s)-coupled receptors.
  • The regulation of IL-1alpha responses by these receptors involves a distinct mechanism that extends beyond the direct inhibition of p38, JNK, MEK, or IKK.
  • Monitoring a small subset of genes can be a sufficient strategy to identify pathway activity for novel compounds, offering a potential paradigm for drug discovery.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...